Mankind Pharma announced its acquisition of Bharat Serums and Vaccines Limited (BSV) from Advent International for approximately Rs 13,630 crore. This deal positions Mankind Pharma as a leader in the Indian women's health and fertility drug market, expanding its portfolio to include high-entry barrier products in critical care with established R&D technology platforms.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.